Resources Contact Us Home
Polymeric medium

Image Number 11 for United States Patent #8129498.

A PBI compound includes imidazole nitrogens at least a portion of which are substituted with a moiety containing a carbonyl group, the substituted imidazole nitrogens being bonded to carbon of the carbonyl group. At least 85% of the nitrogens may be substituted. The carbonyl-containing moiety may include RCO--, where R is alkoxy or haloalkyl. The PBI compound may exhibit a first temperature marking an onset of weight loss corresponding to reversion of the substituted PBI that is less than a second temperature marking an onset of decomposition of an otherwise identical PBI compound without the substituted moiety. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may use more than 5 equivalents in relation to the imidazole nitrogens to be substituted.

  Recently Added Patents
Prodrugs of [4 [4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1H-pyrrolo-pyridin-yl- )-methanones and synthesis thereof
Vehicle grille
Health monitoring of applications in a guest partition
Portable reading device with mode processing
Integrated circuit packaging system with laser hole and method of manufacture thereof
Identifying a characteristic of an individual utilizing facial recognition and providing a display for the individual
Distributed IP-PBX signal processing
  Randomly Featured Patents
Preparation of aliphatic phosphates
Mainframe and power supply arrangement
Ejector for hunting weapons
Disubstituted piperidine derivatives as neuroprotective agents
Automatic retrieval, parsing and application of configuration for a specific-purpose client having a windows-based embedded image with a write-filter
Enhanced automatic operation of wireless telephones
Endothelial-monocyte activating polypeptide III
Mechanism for fast detection of overshift in a floating point unit of a processing device
Hydrogen generator
Use of ursodeoxycholic acid to treat nonalcoholic steatohepatitis